Skip to main content

Treatment Update: Myelodysplastic Syndromes (MDS)

May 11, 2022

Topics Covered

We invite you to learn more about:

  • Myelodysplastic syndromes subtypes
  • Current and emerging treatments
  • Side-effects management
  • The importance of communication with your healthcare team


Program Materials

Transcript will be available soon.


Mikkael A. Sekeres, MD
Professor of Medicine
Chief, Division of Hematology
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL

Program Support

Support for this program is provided by Bristol Myers Squibb and Taiho Oncology.


< Back to Webcasts